"This conference has the advantage of being a more smaller/intimate setting allowing for a more focused discussion on current and relevant topics. Participation from senior industry leaders and as well as regulators supports a richer dialogue and information sharing in a pre-competitive environment."

Executive Director Translational Science, Clinical Evidence Generation, Deep Human Biology (CEG DHBL) Eisai

"This exciting meeting will provide an overview of the current status of neurodegenerative biomarkers and brings together experts in the field to discuss how to accelerate the development of biomarkers for clinical use."

Senior Vice President, The Michael J. Fox Foundation

"The conference will provide a platform to learn about cutting-edge research, best practices, and the latest developments in the biomarkers for neurodegenerative diseases. Additionally, it will offer valuable networking opportunities with experts and peers, fostering collaboration and knowledge-sharing. Attending this conference can provide a comprehensive understanding of the complexities involved in studying these neurodegenerative diseases and help in identifying potential avenues for future research and clinical applications."

Assistant Professor Neurology and Neuroscience, Harvard Medical School - BIDMC

"The summit is a great opportunity for Pharma and Academic leaders to connect and exchange on the advancements of biomarkers development."

Senior Team Leader, AC Immune